• All sections
  • C - Chemistry; metallurgy
  • C07D - Heterocyclic compounds
  • C07D 295/112 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulfur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Patent holdings for IPC class C07D 295/112

Total number of patents in this class: 58

10-year publication summary

3
4
6
5
0
6
5
6
4
2
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

Principal owners for this class

Owner
All patents
This class
Recurium IP Holdings, LLC
138
5
vTv Therapeutics LLC
159
4
The Cooper Health System
32
3
National University Corporation Ehime University
114
3
National University Corporation Kochi University
96
3
Neuropore Therapies, Inc.
39
3
SRI International
974
3
AbbVie Deutschland GmbH & Co. KG
268
2
Iowa State University Research Foundation, Inc.
685
2
Novartis AG
11238
1
Shin-Etsu Chemical Co., Ltd.
5132
1
Life Technologies Corporation
3068
1
Abbvie Inc.
1808
1
The United States of America as represented by the Secretary of the Army
1195
1
Allianz Pharmascience Ltd.
1
1
Changzhou Tronly Advanced Electronic Materials Co., Ltd.
67
1
Changzhou Tronly New Electronic Materials Co.,Ltd.
66
1
Cornell Research Foundation, Inc.
389
1
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
357
1
Institute for Research in Biomedicine
95
1
Other owners 19